Men with advanced prostate cancer taking abiraterone or enzalutamide plus hormone therapy were at higher risk of serious medical issues than their peers undergoing hormone therapy alone.
Michigan Medicine is renowned for groundbreaking clinical, basic science and medical educational research, with nearly 7,000 papers published annually by faculty and trainees. Here, Lab Notes highlights a selection of those articles in addition to ones covered as stories on the Michigan Health Lab blog.
The “Wikiguideline” approach establishes recommendations only when high-quality, hypothesis-confirming evidence is available.
The findings could lead to repurposing drugs for patients with the sometimes-fatal condition.
Some pharmacies participated in the standing order but did not have any naloxone available on the shelf.
Discovery paves the way for new drug targets.